nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—ulcerative colitis	0.216	0.575	CbGaD
Pioglitazone—PTGS1—ulcerative colitis	0.16	0.425	CbGaD
Pioglitazone—PPARG—Olsalazine—ulcerative colitis	0.11	0.209	CbGbCtD
Pioglitazone—PPARG—Balsalazide—ulcerative colitis	0.0983	0.186	CbGbCtD
Pioglitazone—PPARG—Mesalazine—ulcerative colitis	0.0786	0.149	CbGbCtD
Pioglitazone—PPARG—Sulfasalazine—ulcerative colitis	0.0439	0.0831	CbGbCtD
Pioglitazone—PTGS1—Olsalazine—ulcerative colitis	0.0278	0.0526	CbGbCtD
Pioglitazone—PTGS1—Balsalazide—ulcerative colitis	0.0248	0.0469	CbGbCtD
Pioglitazone—PTGS1—Mesalazine—ulcerative colitis	0.0198	0.0375	CbGbCtD
Pioglitazone—SLCO1B1—Sulfasalazine—ulcerative colitis	0.0151	0.0286	CbGbCtD
Pioglitazone—PTGS1—Sulfasalazine—ulcerative colitis	0.0111	0.0209	CbGbCtD
Pioglitazone—CYP2C8—Nicotine—ulcerative colitis	0.00821	0.0155	CbGbCtD
Pioglitazone—CYP3A4—Budesonide—ulcerative colitis	0.00765	0.0145	CbGbCtD
Pioglitazone—CYP2C8—Cholecalciferol—ulcerative colitis	0.00737	0.0139	CbGbCtD
Pioglitazone—CYP2C19—Nicotine—ulcerative colitis	0.00689	0.013	CbGbCtD
Pioglitazone—CYP2C19—Cholecalciferol—ulcerative colitis	0.00618	0.0117	CbGbCtD
Pioglitazone—CYP2C9—Nicotine—ulcerative colitis	0.00573	0.0108	CbGbCtD
Pioglitazone—CYP2D6—Nicotine—ulcerative colitis	0.00524	0.00991	CbGbCtD
Pioglitazone—CYP2C9—Cholecalciferol—ulcerative colitis	0.00514	0.00972	CbGbCtD
Pioglitazone—CYP2C8—Hydrocortisone—ulcerative colitis	0.00512	0.0097	CbGbCtD
Pioglitazone—CYP2D6—Cholecalciferol—ulcerative colitis	0.0047	0.00889	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—ulcerative colitis	0.00428	0.0081	CbGbCtD
Pioglitazone—CYP3A4—Methylprednisolone—ulcerative colitis	0.00342	0.00647	CbGbCtD
Pioglitazone—CYP3A4—Nicotine—ulcerative colitis	0.00333	0.0063	CbGbCtD
Pioglitazone—CYP2C8—Dexamethasone—ulcerative colitis	0.00319	0.00603	CbGbCtD
Pioglitazone—CYP3A4—Cholecalciferol—ulcerative colitis	0.00299	0.00565	CbGbCtD
Pioglitazone—CYP2C19—Dexamethasone—ulcerative colitis	0.00267	0.00506	CbGbCtD
Pioglitazone—CYP3A4—Triamcinolone—ulcerative colitis	0.00259	0.0049	CbGbCtD
Pioglitazone—CYP2C9—Dexamethasone—ulcerative colitis	0.00222	0.00421	CbGbCtD
Pioglitazone—CYP3A4—Betamethasone—ulcerative colitis	0.00222	0.0042	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—ulcerative colitis	0.00219	0.00415	CbGbCtD
Pioglitazone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00208	0.00393	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—ulcerative colitis	0.00207	0.00392	CbGbCtD
Pioglitazone—CYP2D6—Dexamethasone—ulcerative colitis	0.00203	0.00385	CbGbCtD
Pioglitazone—CYP3A4—Dexamethasone—ulcerative colitis	0.00129	0.00245	CbGbCtD
Pioglitazone—Rosiglitazone—PPARG—ulcerative colitis	0.00119	0.473	CrCbGaD
Pioglitazone—PPARG—Methyldopa—Mesalazine—ulcerative colitis	0.00106	1	CbGdCrCtD
Pioglitazone—Rosiglitazone—PTGS1—ulcerative colitis	0.000881	0.349	CrCbGaD
Pioglitazone—Rosiglitazone—ALB—ulcerative colitis	0.000449	0.178	CrCbGaD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000306	0.0267	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transport of organic anions—ALB—ulcerative colitis	0.000267	0.0233	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—HNF4A—ulcerative colitis	0.000216	0.0189	CbGpPWpGaD
Pioglitazone—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000202	0.0177	CbGpPWpGaD
Pioglitazone—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000202	0.0176	CbGpPWpGaD
Pioglitazone—SLCO1B3—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000197	0.0173	CbGpPWpGaD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—TCF4—ulcerative colitis	0.000194	0.017	CbGpPWpGaD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.000182	0.0159	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transport of organic anions—ALB—ulcerative colitis	0.000179	0.0157	CbGpPWpGaD
Pioglitazone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000174	0.0152	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000171	0.0149	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000165	0.0145	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000161	0.014	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000147	0.0129	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000147	0.0129	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000139	0.0122	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000135	0.0118	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—VDR—ulcerative colitis	0.000135	0.0118	CbGpPWpGaD
Pioglitazone—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000134	0.0117	CbGpPWpGaD
Pioglitazone—SLCO1B1—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000133	0.0116	CbGpPWpGaD
Pioglitazone—Vertigo—Mesalazine—ulcerative colitis	0.000124	0.00153	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.000123	0.00152	CcSEcCtD
Pioglitazone—Dyspnoea—Budesonide—ulcerative colitis	0.000123	0.00152	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000123	0.00152	CcSEcCtD
Pioglitazone—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.000123	0.00152	CcSEcCtD
Pioglitazone—Infection—Azathioprine—ulcerative colitis	0.000122	0.00151	CcSEcCtD
Pioglitazone—PPARG—Adipogenesis—MIF—ulcerative colitis	0.000121	0.0106	CbGpPWpGaD
Pioglitazone—Weight increased—Triamcinolone—ulcerative colitis	0.00012	0.00149	CcSEcCtD
Pioglitazone—Weight increased—Methylprednisolone—ulcerative colitis	0.00012	0.00148	CcSEcCtD
Pioglitazone—Skin disorder—Azathioprine—ulcerative colitis	0.00012	0.00148	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000119	0.00147	CcSEcCtD
Pioglitazone—Fatigue—Budesonide—ulcerative colitis	0.000119	0.00147	CcSEcCtD
Pioglitazone—Hypertension—Mesalazine—ulcerative colitis	0.000119	0.00147	CcSEcCtD
Pioglitazone—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000118	0.00145	CcSEcCtD
Pioglitazone—Infestation—Methylprednisolone—ulcerative colitis	0.000118	0.00145	CcSEcCtD
Pioglitazone—Myalgia—Mesalazine—ulcerative colitis	0.000117	0.00145	CcSEcCtD
Pioglitazone—Arthralgia—Mesalazine—ulcerative colitis	0.000117	0.00145	CcSEcCtD
Pioglitazone—Chest pain—Mesalazine—ulcerative colitis	0.000117	0.00145	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000116	0.00144	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000116	0.00143	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000116	0.00143	CcSEcCtD
Pioglitazone—Discomfort—Mesalazine—ulcerative colitis	0.000116	0.00143	CcSEcCtD
Pioglitazone—Myocardial infarction—Triamcinolone—ulcerative colitis	0.000115	0.00143	CcSEcCtD
Pioglitazone—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.000115	0.00142	CcSEcCtD
Pioglitazone—PPARG—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000115	0.0101	CbGpPWpGaD
Pioglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000115	0.01	CbGpPWpGaD
Pioglitazone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000114	0.00996	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Budesonide—ulcerative colitis	0.000114	0.0014	CcSEcCtD
Pioglitazone—Sweating—Methylprednisolone—ulcerative colitis	0.000113	0.00139	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000112	0.00139	CcSEcCtD
Pioglitazone—Oedema—Mesalazine—ulcerative colitis	0.000112	0.00139	CcSEcCtD
Pioglitazone—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000112	0.00139	CcSEcCtD
Pioglitazone—Infection—Mesalazine—ulcerative colitis	0.000111	0.00138	CcSEcCtD
Pioglitazone—Visual impairment—Prednisolone—ulcerative colitis	0.000111	0.00137	CcSEcCtD
Pioglitazone—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.00011	0.00136	CcSEcCtD
Pioglitazone—Nervous system disorder—Mesalazine—ulcerative colitis	0.00011	0.00136	CcSEcCtD
Pioglitazone—Urticaria—Budesonide—ulcerative colitis	0.00011	0.00135	CcSEcCtD
Pioglitazone—Weight increased—Dexamethasone—ulcerative colitis	0.000109	0.00135	CcSEcCtD
Pioglitazone—Weight increased—Betamethasone—ulcerative colitis	0.000109	0.00135	CcSEcCtD
Pioglitazone—Skin disorder—Mesalazine—ulcerative colitis	0.000109	0.00135	CcSEcCtD
Pioglitazone—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000108	0.00134	CcSEcCtD
Pioglitazone—Weight decreased—Dexamethasone—ulcerative colitis	0.000108	0.00134	CcSEcCtD
Pioglitazone—Weight decreased—Betamethasone—ulcerative colitis	0.000108	0.00134	CcSEcCtD
Pioglitazone—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000108	0.00134	CcSEcCtD
Pioglitazone—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000108	0.00134	CcSEcCtD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000108	0.00944	CbGpPWpGaD
Pioglitazone—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000107	0.00132	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000106	0.0093	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000106	0.00131	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000105	0.0013	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000105	0.0013	CcSEcCtD
Pioglitazone—Pharyngitis—Triamcinolone—ulcerative colitis	0.000105	0.0013	CcSEcCtD
Pioglitazone—Eye disorder—Hydrocortisone—ulcerative colitis	0.000105	0.0013	CcSEcCtD
Pioglitazone—Myocardial infarction—Betamethasone—ulcerative colitis	0.000105	0.00129	CcSEcCtD
Pioglitazone—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000105	0.00129	CcSEcCtD
Pioglitazone—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000104	0.00128	CcSEcCtD
Pioglitazone—SLCO1B3—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000103	0.00903	CbGpPWpGaD
Pioglitazone—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000102	0.00126	CcSEcCtD
Pioglitazone—Visual impairment—Methylprednisolone—ulcerative colitis	0.000102	0.00126	CcSEcCtD
Pioglitazone—Hypersensitivity—Budesonide—ulcerative colitis	0.000102	0.00126	CcSEcCtD
Pioglitazone—Feeling abnormal—Azathioprine—ulcerative colitis	0.000101	0.00125	CcSEcCtD
Pioglitazone—Insomnia—Mesalazine—ulcerative colitis	0.000101	0.00125	CcSEcCtD
Pioglitazone—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000101	0.00125	CcSEcCtD
Pioglitazone—Dyspnoea—Mesalazine—ulcerative colitis	0.0001	0.00124	CcSEcCtD
Pioglitazone—Asthenia—Budesonide—ulcerative colitis	9.9e-05	0.00122	CcSEcCtD
Pioglitazone—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	9.89e-05	0.00865	CbGpPWpGaD
Pioglitazone—Eye disorder—Methylprednisolone—ulcerative colitis	9.86e-05	0.00122	CcSEcCtD
Pioglitazone—Cardiac disorder—Methylprednisolone—ulcerative colitis	9.79e-05	0.00121	CcSEcCtD
Pioglitazone—Malnutrition—Hydrocortisone—ulcerative colitis	9.78e-05	0.00121	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Mesalazine—ulcerative colitis	9.69e-05	0.0012	CcSEcCtD
Pioglitazone—Fatigue—Mesalazine—ulcerative colitis	9.67e-05	0.0012	CcSEcCtD
Pioglitazone—Erectile dysfunction—Prednisone—ulcerative colitis	9.61e-05	0.00119	CcSEcCtD
Pioglitazone—Immune system disorder—Methylprednisolone—ulcerative colitis	9.53e-05	0.00118	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methylprednisolone—ulcerative colitis	9.51e-05	0.00117	CcSEcCtD
Pioglitazone—Weight increased—Prednisone—ulcerative colitis	9.5e-05	0.00117	CcSEcCtD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	9.47e-05	0.00828	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	9.47e-05	0.00828	CbGpPWpGaD
Pioglitazone—Weight decreased—Prednisone—ulcerative colitis	9.44e-05	0.00117	CcSEcCtD
Pioglitazone—Diarrhoea—Budesonide—ulcerative colitis	9.44e-05	0.00117	CcSEcCtD
Pioglitazone—Hyperglycaemia—Prednisone—ulcerative colitis	9.42e-05	0.00116	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisolone—ulcerative colitis	9.29e-05	0.00115	CcSEcCtD
Pioglitazone—Visual impairment—Betamethasone—ulcerative colitis	9.25e-05	0.00114	CcSEcCtD
Pioglitazone—Visual impairment—Dexamethasone—ulcerative colitis	9.25e-05	0.00114	CcSEcCtD
Pioglitazone—Feeling abnormal—Mesalazine—ulcerative colitis	9.25e-05	0.00114	CcSEcCtD
Pioglitazone—Malnutrition—Methylprednisolone—ulcerative colitis	9.18e-05	0.00113	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisone—ulcerative colitis	9.17e-05	0.00113	CcSEcCtD
Pioglitazone—Angioedema—Prednisolone—ulcerative colitis	9.15e-05	0.00113	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisone—ulcerative colitis	9.12e-05	0.00113	CcSEcCtD
Pioglitazone—Dizziness—Budesonide—ulcerative colitis	9.12e-05	0.00113	CcSEcCtD
Pioglitazone—Hypersensitivity—Azathioprine—ulcerative colitis	9.07e-05	0.00112	CcSEcCtD
Pioglitazone—Ill-defined disorder—Hydrocortisone—ulcerative colitis	9.07e-05	0.00112	CcSEcCtD
Pioglitazone—Malaise—Prednisolone—ulcerative colitis	9.03e-05	0.00112	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	9e-05	0.00787	CbGpPWpGaD
Pioglitazone—Vertigo—Prednisolone—ulcerative colitis	8.99e-05	0.00111	CcSEcCtD
Pioglitazone—Eye disorder—Betamethasone—ulcerative colitis	8.97e-05	0.00111	CcSEcCtD
Pioglitazone—Eye disorder—Dexamethasone—ulcerative colitis	8.97e-05	0.00111	CcSEcCtD
Pioglitazone—Angioedema—Hydrocortisone—ulcerative colitis	8.93e-05	0.0011	CcSEcCtD
Pioglitazone—Urticaria—Mesalazine—ulcerative colitis	8.91e-05	0.0011	CcSEcCtD
Pioglitazone—Back pain—Triamcinolone—ulcerative colitis	8.9e-05	0.0011	CcSEcCtD
Pioglitazone—Malaise—Hydrocortisone—ulcerative colitis	8.82e-05	0.00109	CcSEcCtD
Pioglitazone—Vertigo—Hydrocortisone—ulcerative colitis	8.78e-05	0.00109	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	8.73e-05	0.00763	CbGpPWpGaD
Pioglitazone—Headache—Budesonide—ulcerative colitis	8.64e-05	0.00107	CcSEcCtD
Pioglitazone—Hypertension—Prednisolone—ulcerative colitis	8.64e-05	0.00107	CcSEcCtD
Pioglitazone—Ill-defined disorder—Triamcinolone—ulcerative colitis	8.54e-05	0.00106	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methylprednisolone—ulcerative colitis	8.52e-05	0.00105	CcSEcCtD
Pioglitazone—Hypertension—Hydrocortisone—ulcerative colitis	8.44e-05	0.00104	CcSEcCtD
Pioglitazone—Diarrhoea—Azathioprine—ulcerative colitis	8.43e-05	0.00104	CcSEcCtD
Pioglitazone—Discomfort—Prednisolone—ulcerative colitis	8.42e-05	0.00104	CcSEcCtD
Pioglitazone—Angioedema—Triamcinolone—ulcerative colitis	8.41e-05	0.00104	CcSEcCtD
Pioglitazone—Angioedema—Methylprednisolone—ulcerative colitis	8.39e-05	0.00104	CcSEcCtD
Pioglitazone—Myalgia—Hydrocortisone—ulcerative colitis	8.32e-05	0.00103	CcSEcCtD
Pioglitazone—Malaise—Triamcinolone—ulcerative colitis	8.3e-05	0.00103	CcSEcCtD
Pioglitazone—Malaise—Methylprednisolone—ulcerative colitis	8.28e-05	0.00102	CcSEcCtD
Pioglitazone—Vertigo—Triamcinolone—ulcerative colitis	8.27e-05	0.00102	CcSEcCtD
Pioglitazone—Hypersensitivity—Mesalazine—ulcerative colitis	8.27e-05	0.00102	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.26e-05	0.00102	CcSEcCtD
Pioglitazone—Vertigo—Methylprednisolone—ulcerative colitis	8.25e-05	0.00102	CcSEcCtD
Pioglitazone—Discomfort—Hydrocortisone—ulcerative colitis	8.22e-05	0.00102	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—ulcerative colitis	8.21e-05	0.00101	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisolone—ulcerative colitis	8.17e-05	0.00101	CcSEcCtD
Pioglitazone—Oedema—Prednisolone—ulcerative colitis	8.17e-05	0.00101	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	8.16e-05	0.00714	CbGpPWpGaD
Pioglitazone—Dizziness—Azathioprine—ulcerative colitis	8.14e-05	0.00101	CcSEcCtD
Pioglitazone—Asthenia—Mesalazine—ulcerative colitis	8.05e-05	0.000995	CcSEcCtD
Pioglitazone—Anaphylactic shock—Hydrocortisone—ulcerative colitis	7.98e-05	0.000986	CcSEcCtD
Pioglitazone—Oedema—Hydrocortisone—ulcerative colitis	7.98e-05	0.000986	CcSEcCtD
Pioglitazone—Hypertension—Triamcinolone—ulcerative colitis	7.95e-05	0.000982	CcSEcCtD
Pioglitazone—Hypertension—Methylprednisolone—ulcerative colitis	7.93e-05	0.00098	CcSEcCtD
Pioglitazone—Infection—Hydrocortisone—ulcerative colitis	7.93e-05	0.000979	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisolone—ulcerative colitis	7.9e-05	0.000976	CcSEcCtD
Pioglitazone—Myalgia—Triamcinolone—ulcerative colitis	7.84e-05	0.000968	CcSEcCtD
Pioglitazone—Nervous system disorder—Hydrocortisone—ulcerative colitis	7.82e-05	0.000967	CcSEcCtD
Pioglitazone—Arthralgia—Methylprednisolone—ulcerative colitis	7.82e-05	0.000966	CcSEcCtD
Pioglitazone—Myalgia—Methylprednisolone—ulcerative colitis	7.82e-05	0.000966	CcSEcCtD
Pioglitazone—Eye disorder—Prednisone—ulcerative colitis	7.81e-05	0.000965	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	7.76e-05	0.00096	CcSEcCtD
Pioglitazone—Skin disorder—Hydrocortisone—ulcerative colitis	7.75e-05	0.000958	CcSEcCtD
Pioglitazone—Ill-defined disorder—Betamethasone—ulcerative colitis	7.75e-05	0.000958	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dexamethasone—ulcerative colitis	7.75e-05	0.000958	CcSEcCtD
Pioglitazone—Discomfort—Triamcinolone—ulcerative colitis	7.74e-05	0.000957	CcSEcCtD
Pioglitazone—Discomfort—Methylprednisolone—ulcerative colitis	7.73e-05	0.000955	CcSEcCtD
Pioglitazone—Headache—Azathioprine—ulcerative colitis	7.72e-05	0.000953	CcSEcCtD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—TNF—ulcerative colitis	7.71e-05	0.00675	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	7.71e-05	0.000953	CcSEcCtD
Pioglitazone—Diarrhoea—Mesalazine—ulcerative colitis	7.68e-05	0.000949	CcSEcCtD
Pioglitazone—Angioedema—Betamethasone—ulcerative colitis	7.63e-05	0.000943	CcSEcCtD
Pioglitazone—Angioedema—Dexamethasone—ulcerative colitis	7.63e-05	0.000943	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—ulcerative colitis	7.55e-05	0.000933	CcSEcCtD
Pioglitazone—Malaise—Betamethasone—ulcerative colitis	7.53e-05	0.000931	CcSEcCtD
Pioglitazone—Malaise—Dexamethasone—ulcerative colitis	7.53e-05	0.000931	CcSEcCtD
Pioglitazone—Anaphylactic shock—Triamcinolone—ulcerative colitis	7.51e-05	0.000928	CcSEcCtD
Pioglitazone—Oedema—Triamcinolone—ulcerative colitis	7.51e-05	0.000928	CcSEcCtD
Pioglitazone—Vertigo—Betamethasone—ulcerative colitis	7.5e-05	0.000927	CcSEcCtD
Pioglitazone—Vertigo—Dexamethasone—ulcerative colitis	7.5e-05	0.000927	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methylprednisolone—ulcerative colitis	7.5e-05	0.000926	CcSEcCtD
Pioglitazone—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	7.49e-05	0.00655	CbGpPWpGaD
Pioglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	7.47e-05	0.00653	CbGpPWpGaD
Pioglitazone—Infection—Triamcinolone—ulcerative colitis	7.46e-05	0.000922	CcSEcCtD
Pioglitazone—Infection—Methylprednisolone—ulcerative colitis	7.45e-05	0.00092	CcSEcCtD
Pioglitazone—Dizziness—Mesalazine—ulcerative colitis	7.42e-05	0.000917	CcSEcCtD
Pioglitazone—Insomnia—Prednisolone—ulcerative colitis	7.39e-05	0.000913	CcSEcCtD
Pioglitazone—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.35e-05	0.000908	CcSEcCtD
Pioglitazone—Skin disorder—Methylprednisolone—ulcerative colitis	7.28e-05	0.0009	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—ulcerative colitis	7.27e-05	0.000899	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.27e-05	0.000898	CcSEcCtD
Pioglitazone—Hyperhidrosis—Triamcinolone—ulcerative colitis	7.26e-05	0.000897	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	7.25e-05	0.000895	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	7.23e-05	0.00632	CbGpPWpGaD
Pioglitazone—Insomnia—Hydrocortisone—ulcerative colitis	7.22e-05	0.000892	CcSEcCtD
Pioglitazone—Hypertension—Betamethasone—ulcerative colitis	7.21e-05	0.000891	CcSEcCtD
Pioglitazone—Hypertension—Dexamethasone—ulcerative colitis	7.21e-05	0.000891	CcSEcCtD
Pioglitazone—Myalgia—Dexamethasone—ulcerative colitis	7.11e-05	0.000879	CcSEcCtD
Pioglitazone—Myalgia—Betamethasone—ulcerative colitis	7.11e-05	0.000879	CcSEcCtD
Pioglitazone—Headache—Mesalazine—ulcerative colitis	7.03e-05	0.000869	CcSEcCtD
Pioglitazone—Discomfort—Betamethasone—ulcerative colitis	7.02e-05	0.000868	CcSEcCtD
Pioglitazone—Discomfort—Dexamethasone—ulcerative colitis	7.02e-05	0.000868	CcSEcCtD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	7e-05	0.00612	CbGpPWpGaD
Pioglitazone—SLCO1B1—Bile acid and bile salt metabolism—ALB—ulcerative colitis	6.94e-05	0.00607	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	6.89e-05	0.000851	CcSEcCtD
Pioglitazone—Fatigue—Hydrocortisone—ulcerative colitis	6.88e-05	0.00085	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	6.84e-05	0.000846	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	6.83e-05	0.000844	CcSEcCtD
Pioglitazone—Anaphylactic shock—Betamethasone—ulcerative colitis	6.82e-05	0.000842	CcSEcCtD
Pioglitazone—Oedema—Betamethasone—ulcerative colitis	6.82e-05	0.000842	CcSEcCtD
Pioglitazone—Anaphylactic shock—Dexamethasone—ulcerative colitis	6.82e-05	0.000842	CcSEcCtD
Pioglitazone—Oedema—Dexamethasone—ulcerative colitis	6.82e-05	0.000842	CcSEcCtD
Pioglitazone—Insomnia—Triamcinolone—ulcerative colitis	6.79e-05	0.00084	CcSEcCtD
Pioglitazone—Insomnia—Methylprednisolone—ulcerative colitis	6.78e-05	0.000838	CcSEcCtD
Pioglitazone—Infection—Betamethasone—ulcerative colitis	6.77e-05	0.000837	CcSEcCtD
Pioglitazone—Infection—Dexamethasone—ulcerative colitis	6.77e-05	0.000837	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	6.75e-05	0.0059	CbGpPWpGaD
Pioglitazone—Ill-defined disorder—Prednisone—ulcerative colitis	6.75e-05	0.000834	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—ulcerative colitis	6.73e-05	0.000832	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—ulcerative colitis	6.72e-05	0.000831	CcSEcCtD
Pioglitazone—Dyspnoea—Triamcinolone—ulcerative colitis	6.7e-05	0.000828	CcSEcCtD
Pioglitazone—Nervous system disorder—Betamethasone—ulcerative colitis	6.68e-05	0.000826	CcSEcCtD
Pioglitazone—Nervous system disorder—Dexamethasone—ulcerative colitis	6.68e-05	0.000826	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—ulcerative colitis	6.65e-05	0.000821	CcSEcCtD
Pioglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	6.64e-05	0.00581	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Betamethasone—ulcerative colitis	6.59e-05	0.000814	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dexamethasone—ulcerative colitis	6.59e-05	0.000814	CcSEcCtD
Pioglitazone—Feeling abnormal—Hydrocortisone—ulcerative colitis	6.57e-05	0.000812	CcSEcCtD
Pioglitazone—Malaise—Prednisone—ulcerative colitis	6.56e-05	0.00081	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—ulcerative colitis	6.53e-05	0.000807	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—ulcerative colitis	6.49e-05	0.000802	CcSEcCtD
Pioglitazone—Fatigue—Triamcinolone—ulcerative colitis	6.48e-05	0.0008	CcSEcCtD
Pioglitazone—Fatigue—Methylprednisolone—ulcerative colitis	6.46e-05	0.000799	CcSEcCtD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	6.36e-05	0.00556	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	6.36e-05	0.00556	CbGpPWpGaD
Pioglitazone—Urticaria—Hydrocortisone—ulcerative colitis	6.34e-05	0.000783	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—ulcerative colitis	6.28e-05	0.000776	CcSEcCtD
Pioglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	6.25e-05	0.00546	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	6.25e-05	0.00546	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	6.24e-05	0.00546	CbGpPWpGaD
Pioglitazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	6.23e-05	0.00545	CbGpPWpGaD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—IL6—ulcerative colitis	6.22e-05	0.00544	CbGpPWpGaD
Pioglitazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	6.22e-05	0.00544	CbGpPWpGaD
Pioglitazone—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.21e-05	0.000767	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.21e-05	0.000767	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—ulcerative colitis	6.19e-05	0.000765	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—ulcerative colitis	6.19e-05	0.000765	CcSEcCtD
Pioglitazone—Feeling abnormal—Triamcinolone—ulcerative colitis	6.19e-05	0.000765	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	6.18e-05	0.0054	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.18e-05	0.000763	CcSEcCtD
Pioglitazone—Insomnia—Dexamethasone—ulcerative colitis	6.16e-05	0.000762	CcSEcCtD
Pioglitazone—Insomnia—Betamethasone—ulcerative colitis	6.16e-05	0.000762	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.15e-05	0.00076	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—ulcerative colitis	6.12e-05	0.000756	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	6.08e-05	0.00531	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Prednisolone—ulcerative colitis	6.02e-05	0.000744	CcSEcCtD
Pioglitazone—Urticaria—Triamcinolone—ulcerative colitis	5.97e-05	0.000737	CcSEcCtD
Pioglitazone—Urticaria—Methylprednisolone—ulcerative colitis	5.95e-05	0.000736	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—ulcerative colitis	5.94e-05	0.000734	CcSEcCtD
Pioglitazone—Oedema—Prednisone—ulcerative colitis	5.94e-05	0.000734	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—ulcerative colitis	5.92e-05	0.00518	CbGpPWpGaD
Pioglitazone—Infection—Prednisone—ulcerative colitis	5.9e-05	0.000729	CcSEcCtD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	5.9e-05	0.00516	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	5.88e-05	0.000727	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	5.88e-05	0.000727	CcSEcCtD
Pioglitazone—Hypersensitivity—Hydrocortisone—ulcerative colitis	5.88e-05	0.000726	CcSEcCtD
Pioglitazone—Fatigue—Betamethasone—ulcerative colitis	5.88e-05	0.000726	CcSEcCtD
Pioglitazone—Fatigue—Dexamethasone—ulcerative colitis	5.88e-05	0.000726	CcSEcCtD
Pioglitazone—Nervous system disorder—Prednisone—ulcerative colitis	5.82e-05	0.000719	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—ulcerative colitis	5.77e-05	0.000712	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	5.75e-05	0.00503	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Prednisone—ulcerative colitis	5.74e-05	0.000709	CcSEcCtD
Pioglitazone—Asthenia—Hydrocortisone—ulcerative colitis	5.72e-05	0.000707	CcSEcCtD
Pioglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	5.7e-05	0.00498	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	5.69e-05	0.00498	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Betamethasone—ulcerative colitis	5.62e-05	0.000694	CcSEcCtD
Pioglitazone—Feeling abnormal—Dexamethasone—ulcerative colitis	5.62e-05	0.000694	CcSEcCtD
Pioglitazone—PPARG—Gene Expression—ZFP90—ulcerative colitis	5.53e-05	0.00484	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Triamcinolone—ulcerative colitis	5.53e-05	0.000684	CcSEcCtD
Pioglitazone—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.52e-05	0.000682	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	5.49e-05	0.0048	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.48e-05	0.0048	CbGpPWpGaD
Pioglitazone—Diarrhoea—Hydrocortisone—ulcerative colitis	5.46e-05	0.000675	CcSEcCtD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.43e-05	0.00475	CbGpPWpGaD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.42e-05	0.00474	CbGpPWpGaD
Pioglitazone—Urticaria—Dexamethasone—ulcerative colitis	5.41e-05	0.000669	CcSEcCtD
Pioglitazone—Urticaria—Betamethasone—ulcerative colitis	5.41e-05	0.000669	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.41e-05	0.000668	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—ulcerative colitis	5.4e-05	0.000668	CcSEcCtD
Pioglitazone—Asthenia—Triamcinolone—ulcerative colitis	5.39e-05	0.000666	CcSEcCtD
Pioglitazone—Asthenia—Methylprednisolone—ulcerative colitis	5.38e-05	0.000665	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—ulcerative colitis	5.37e-05	0.000663	CcSEcCtD
Pioglitazone—PPARG—Generic Transcription Pathway—NR5A2—ulcerative colitis	5.28e-05	0.00462	CbGpPWpGaD
Pioglitazone—Dizziness—Hydrocortisone—ulcerative colitis	5.28e-05	0.000652	CcSEcCtD
Pioglitazone—Diarrhoea—Methylprednisolone—ulcerative colitis	5.13e-05	0.000634	CcSEcCtD
Pioglitazone—PPARG—Developmental Biology—ARPC2—ulcerative colitis	5.12e-05	0.00448	CbGpPWpGaD
Pioglitazone—Fatigue—Prednisone—ulcerative colitis	5.12e-05	0.000632	CcSEcCtD
Pioglitazone—Headache—Prednisolone—ulcerative colitis	5.12e-05	0.000632	CcSEcCtD
Pioglitazone—Headache—Hydrocortisone—ulcerative colitis	5e-05	0.000618	CcSEcCtD
Pioglitazone—PPARG—Developmental Biology—NR5A2—ulcerative colitis	4.97e-05	0.00434	CbGpPWpGaD
Pioglitazone—Dizziness—Triamcinolone—ulcerative colitis	4.97e-05	0.000614	CcSEcCtD
Pioglitazone—Dizziness—Methylprednisolone—ulcerative colitis	4.96e-05	0.000612	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	4.9e-05	0.00429	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.9e-05	0.00429	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Prednisone—ulcerative colitis	4.89e-05	0.000604	CcSEcCtD
Pioglitazone—Asthenia—Dexamethasone—ulcerative colitis	4.89e-05	0.000604	CcSEcCtD
Pioglitazone—Asthenia—Betamethasone—ulcerative colitis	4.89e-05	0.000604	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.81e-05	0.00421	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.81e-05	0.00421	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—GHRL—ulcerative colitis	4.72e-05	0.00413	CbGpPWpGaD
Pioglitazone—Urticaria—Prednisone—ulcerative colitis	4.72e-05	0.000583	CcSEcCtD
Pioglitazone—Headache—Triamcinolone—ulcerative colitis	4.71e-05	0.000582	CcSEcCtD
Pioglitazone—Headache—Methylprednisolone—ulcerative colitis	4.7e-05	0.00058	CcSEcCtD
Pioglitazone—Diarrhoea—Betamethasone—ulcerative colitis	4.66e-05	0.000576	CcSEcCtD
Pioglitazone—Diarrhoea—Dexamethasone—ulcerative colitis	4.66e-05	0.000576	CcSEcCtD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—RELA—ulcerative colitis	4.66e-05	0.00407	CbGpPWpGaD
Pioglitazone—Dizziness—Dexamethasone—ulcerative colitis	4.51e-05	0.000557	CcSEcCtD
Pioglitazone—Dizziness—Betamethasone—ulcerative colitis	4.51e-05	0.000557	CcSEcCtD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.37e-05	0.00383	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Prednisone—ulcerative colitis	4.37e-05	0.00054	CcSEcCtD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—RELA—ulcerative colitis	4.32e-05	0.00377	CbGpPWpGaD
Pioglitazone—Headache—Betamethasone—ulcerative colitis	4.27e-05	0.000528	CcSEcCtD
Pioglitazone—Headache—Dexamethasone—ulcerative colitis	4.27e-05	0.000528	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—ulcerative colitis	4.26e-05	0.000526	CcSEcCtD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.15e-05	0.00363	CbGpPWpGaD
Pioglitazone—Diarrhoea—Prednisone—ulcerative colitis	4.06e-05	0.000502	CcSEcCtD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.02e-05	0.00352	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	4e-05	0.0035	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.99e-05	0.00349	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	3.96e-05	0.00346	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	3.94e-05	0.00344	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—NFKB1—ulcerative colitis	3.93e-05	0.00344	CbGpPWpGaD
Pioglitazone—Dizziness—Prednisone—ulcerative colitis	3.93e-05	0.000485	CcSEcCtD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.78e-05	0.0033	CbGpPWpGaD
Pioglitazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	3.76e-05	0.00329	CbGpPWpGaD
Pioglitazone—Headache—Prednisone—ulcerative colitis	3.72e-05	0.00046	CcSEcCtD
Pioglitazone—PPARG—Developmental Biology—LAMB1—ulcerative colitis	3.66e-05	0.0032	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—NFKB1—ulcerative colitis	3.64e-05	0.00318	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	3.62e-05	0.00317	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	3.58e-05	0.00313	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	3.57e-05	0.00312	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—STAT3—ulcerative colitis	3.53e-05	0.00309	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.23e-05	0.00283	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.23e-05	0.00283	CbGpPWpGaD
Pioglitazone—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.21e-05	0.00281	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TCF4—ulcerative colitis	3.2e-05	0.0028	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—ulcerative colitis	3.06e-05	0.00267	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—ulcerative colitis	3.03e-05	0.00265	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	3.02e-05	0.00264	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3e-05	0.00262	CbGpPWpGaD
Pioglitazone—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	2.95e-05	0.00258	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—HNF4A—ulcerative colitis	2.95e-05	0.00258	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MAML2—ulcerative colitis	2.87e-05	0.00251	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—ulcerative colitis	2.83e-05	0.00248	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HNF4A—ulcerative colitis	2.78e-05	0.00243	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CHP1—ulcerative colitis	2.76e-05	0.00242	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.75e-05	0.00241	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	2.72e-05	0.00238	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.68e-05	0.00234	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	2.64e-05	0.00231	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.63e-05	0.0023	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	2.6e-05	0.00228	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.59e-05	0.00226	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NR5A2—ulcerative colitis	2.54e-05	0.00222	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.49e-05	0.00218	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	2.46e-05	0.00215	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.39e-05	0.00209	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—DLD—ulcerative colitis	2.39e-05	0.00209	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CHP1—ulcerative colitis	2.36e-05	0.00206	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	2.32e-05	0.00203	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	2.29e-05	0.002	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.21e-05	0.00193	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.18e-05	0.00191	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—STAT3—ulcerative colitis	2.15e-05	0.00188	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	2.14e-05	0.00187	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.12e-05	0.00186	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	2.12e-05	0.00185	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—DLD—ulcerative colitis	2.04e-05	0.00178	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.01e-05	0.00176	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TGFB1—ulcerative colitis	1.99e-05	0.00174	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TNF—ulcerative colitis	1.86e-05	0.00163	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CHP1—ulcerative colitis	1.86e-05	0.00162	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—VDR—ulcerative colitis	1.84e-05	0.00161	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	1.78e-05	0.00156	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.74e-05	0.00152	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.72e-05	0.00151	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CHP1—ulcerative colitis	1.65e-05	0.00144	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.61e-05	0.00141	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—DLD—ulcerative colitis	1.6e-05	0.0014	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—ulcerative colitis	1.5e-05	0.00131	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	1.44e-05	0.00126	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.43e-05	0.00125	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—DLD—ulcerative colitis	1.43e-05	0.00125	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—HNF4A—ulcerative colitis	1.42e-05	0.00124	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.4e-05	0.00122	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAML2—ulcerative colitis	1.38e-05	0.00121	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.26e-05	0.0011	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—ulcerative colitis	1.16e-05	0.00101	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.16e-05	0.00101	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS1—ulcerative colitis	1.15e-05	0.00101	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.13e-05	0.000992	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.08e-05	0.000945	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.08e-05	0.000943	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.07e-05	0.000933	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—ulcerative colitis	1.06e-05	0.000927	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CALM3—ulcerative colitis	1.04e-05	0.000908	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—JAK2—ulcerative colitis	1.01e-05	0.000881	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1e-05	0.000874	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.92e-06	0.000868	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS1—ulcerative colitis	9.84e-06	0.000861	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—RELA—ulcerative colitis	9.76e-06	0.000853	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.68e-06	0.000846	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CHP1—ulcerative colitis	9.52e-06	0.000833	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—DLD—ulcerative colitis	9.21e-06	0.000805	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.92e-06	0.00078	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CALM3—ulcerative colitis	8.86e-06	0.000775	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—VDR—ulcerative colitis	8.84e-06	0.000773	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CHP1—ulcerative colitis	8.76e-06	0.000766	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CHP1—ulcerative colitis	8.68e-06	0.000759	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.48e-06	0.000741	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.47e-06	0.000741	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—ulcerative colitis	8.32e-06	0.000727	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—NFKB1—ulcerative colitis	8.23e-06	0.00072	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—DLD—ulcerative colitis	8.22e-06	0.000719	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.14e-06	0.000712	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ABCB1—ulcerative colitis	8.08e-06	0.000706	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	7.75e-06	0.000678	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.62e-06	0.000667	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—DLD—ulcerative colitis	7.56e-06	0.000661	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.54e-06	0.000659	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ADCY5—ulcerative colitis	7.53e-06	0.000659	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—DLD—ulcerative colitis	7.5e-06	0.000656	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—STAT3—ulcerative colitis	7.39e-06	0.000647	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.25e-06	0.000634	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CALM3—ulcerative colitis	6.98e-06	0.00061	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ABCB1—ulcerative colitis	6.89e-06	0.000603	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TGFB1—ulcerative colitis	6.85e-06	0.000599	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.78e-06	0.000593	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.67e-06	0.000583	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ADCY5—ulcerative colitis	6.43e-06	0.000562	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—ulcerative colitis	6.4e-06	0.00056	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CALM3—ulcerative colitis	6.21e-06	0.000543	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.93e-06	0.000519	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CHP1—ulcerative colitis	5.73e-06	0.000501	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPARG—ulcerative colitis	5.62e-06	0.000491	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	5.43e-06	0.000474	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—ulcerative colitis	5.17e-06	0.000452	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	5.06e-06	0.000443	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—ulcerative colitis	5.05e-06	0.000442	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DLD—ulcerative colitis	4.94e-06	0.000432	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.87e-06	0.000426	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—ulcerative colitis	4.83e-06	0.000422	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ADCY5—ulcerative colitis	4.5e-06	0.000394	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS1—ulcerative colitis	4.45e-06	0.000389	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—ulcerative colitis	4.42e-06	0.000387	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.38e-06	0.000383	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.35e-06	0.00038	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—ulcerative colitis	4.31e-06	0.000377	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CALM3—ulcerative colitis	4.01e-06	0.000351	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS1—ulcerative colitis	3.97e-06	0.000348	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.96e-06	0.000347	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.91e-06	0.000342	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.83e-06	0.000335	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—ulcerative colitis	3.77e-06	0.00033	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—ulcerative colitis	3.77e-06	0.00033	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS1—ulcerative colitis	3.66e-06	0.00032	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.62e-06	0.000317	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CALM3—ulcerative colitis	3.58e-06	0.000313	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.56e-06	0.000312	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.42e-06	0.000299	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—ulcerative colitis	3.39e-06	0.000297	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—ulcerative colitis	3.36e-06	0.000294	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.29e-06	0.000288	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.26e-06	0.000285	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.12e-06	0.000273	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—ulcerative colitis	3.12e-06	0.000273	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—ulcerative colitis	3.02e-06	0.000264	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	2.97e-06	0.00026	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ADCY5—ulcerative colitis	2.91e-06	0.000254	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—ulcerative colitis	2.78e-06	0.000243	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.64e-06	0.000231	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADCY5—ulcerative colitis	2.6e-06	0.000227	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—ulcerative colitis	2.56e-06	0.000224	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.54e-06	0.000222	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.39e-06	0.000209	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.39e-06	0.000209	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.37e-06	0.000207	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—ulcerative colitis	2.17e-06	0.00019	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.15e-06	0.000188	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—ulcerative colitis	1.95e-06	0.000171	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.94e-06	0.000169	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.78e-06	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.77e-06	0.000154	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—ulcerative colitis	1.74e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—ulcerative colitis	1.71e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.67e-06	0.000146	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—ulcerative colitis	1.6e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—ulcerative colitis	1.59e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.56e-06	0.000137	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—ulcerative colitis	1.52e-06	0.000133	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.4e-06	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.39e-06	0.000121	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.16e-06	0.000102	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—ulcerative colitis	1.05e-06	9.16e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	9.16e-07	8.01e-05	CbGpPWpGaD
